Show items per page
Elements: 113
Page 3 on 6
 TitleAuthors / EditorsDate
add to browser selection
Long-term efficacy and safety of first-line therapy with once-daily saquinavir/ritonavir Ananworanich, Jintanat; Gayet-Ageron, Angèle; Ruxrungtham, Kiat; Chetchotisakd, Ploenchan; ... Hirschel, Bernard 2008
add to browser selection
Antiretroviral treatment during pregnancy Keiser, Olivia; Gayet-Ageron, Angèle; Rudin, Christoph; Brinkhof, M. W.; ... de Tejada, B. M. 2008
add to browser selection
Long-term safety and effectiveness of ritonavir, nelfinavir, and lopinavir/ritonavir in antiretroviral-experienced HIV-infected children Rudin, Christoph; Burri, Marcus; Shen, Yang; Rode, Richard; Nadal, David 2008
add to browser selection
Treatment and prognosis of AIDS-related lymphoma in the era of highly active antiretroviral therapy: findings from the Swiss HIV Cohort Study Simcock, Mathew; Blasko, Monika; Karrer, Urs; Bertisch, Barbara; ... Koller, M. T. 2007
add to browser selection
The role of compartment penetration in PI-monotherapy: the Atazanavir-Ritonavir Monomaintenance (ATARITMO) Trial Vernazza, Pietro; Daneel, Synove; Schiffer, Veronique; Decosterd, Laurent; ... Hirschel, Bernard 2007
add to browser selection
CD4+ T-cell count increase in HIV-1-infected patients with suppressed viral load within 1 year after start of antiretroviral therapy Wolbers, Marcel; Battegay, Manuel; Hirschel, Bernard; Furrer, Hansjakob; ... Bucher, H. C. 2007
add to browser selection
Predictors of optimal viral suppression in patients switched to abacavir, lamivudine, and zidovudine: the Swiss HIV Cohort Study Wolbers, Marcel; Opravil, Milos; von Wyl, Viktor; Hirschel, Bernard; ... Bucher, H. C. 2007
add to browser selection
Hypogonadism in HIV-1-infected men is common and does not resolve during antiretroviral therapy Wunder, D. M.; Bersinger, N. A.; Fux, C. A.; Mueller, N. J.; ... Furrer, Hansjakob 2007
add to browser selection
Short-term clinical disease progression in HIV-1-positive patients taking combination antiretroviral therapy: the EuroSIDA risk-score Mocroft, Amanda; Ledergerber, Bruno; Zilmer, Kai; Kirk, Ole; ... Lundgren, J. D. 2007
add to browser selection
Reducing tuberculosis incidence by tuberculin skin testing, preventive treatment, and antiretroviral therapy in an area of low tuberculosis transmission Elzi, Luigia; Schlegel, Matthias; Weber, Rainer; Hirschel, Bernard; ... Furrer, Hansjakob 2007
add to browser selection
Late presentation of HIV-infected individuals Battegay, Manuel; Fluckiger, Ursula; Hirschel, Bernard; Furrer, Hansjakob 2007
add to browser selection
Ferritin levels during structured treatment interruption of highly active antiretroviral therapy Boom, J.; Kosters, E.; Duncombe, C.; Kerr, S.; ... Ananworanich, J. 2007
add to browser selection
Intermittent therapy for the treatment of chronic HIV infection Ananworanich, Jintanat; Hirschel, Bernard 2007
add to browser selection
Immunological recovery and antiretroviral therapy in HIV-1 infection Battegay, Manuel; Nuesch, Reto; Hirschel, Bernard; Kaufmann, G. R. 2006
add to browser selection
CD4-guided scheduled treatment interruptions compared with continuous therapy for patients infected with HIV-1: results of the Staccato randomised trial Ananworanich, Jintanat; Gayet-Ageron, Angèle; Le Braz, Michelle; Prasithsirikul, Wisit; ... Hirschel, Bernard 2006
add to browser selection
Treatment of psoriasis with alefacept in patients with hepatitis C infection: a report of two cases Thaci, Diamant; Patzold, S.; Kaufmann, Roland; Boehncke, Wolf-Henning 2005
add to browser selection
HIV-1 p24 may persist during long-term highly active antiretroviral therapy, increases little during short treatment breaks, and its rebound after treatment stop correlates with CD4(+) T cell loss Schupbach, Jorg; Gunthard, Huldrych; Joos, Beda; Fischer, Marek; ... Hirschel, Bernard 2005
add to browser selection
Modeling the influence of APOC3, APOE, and TNF polymorphisms on the risk of antiretroviral therapy-associated lipid disorders Tarr, P. E.; Taffe, Patrick; Bleiber, Gabriela; Furrer, Hansjakob; ... Telenti, Amalio 2005
add to browser selection
Characteristics, determinants, and clinical relevance of CD4 T cell recovery to <500 cells/microL in HIV type 1-infected individuals receiving potent antiretroviral therapy Kaufmann, G. R.; Furrer, Hansjakob; Ledergerber, Bruno; Perrin, Luc; ... Battegay, Manuel 2005
add to browser selection
A prospective, randomized trial of structured treatment interruption for patients with chronic HIV type 1 infection Cardiello, Peter; Hassink, Elly; Ananworanich, Jintanat; Srasuebkul, Preeyaporn; ... Cooper, David 2005
| 1 | 2 | 3 | 4 | 5 | 6 |